Kuznicki Law PLLC notifies investors that a class action has commenced in the United States District Court for the Central District of California on behalf of shareholders of Barclays PLC who purchased shares between July 22, 2019 and October 12, 2023.
Barclays and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
The alleged false and misleading statements and omissions include, but are not limited to, that: (i) contrary to false public assertions, the Company’s former CEO, James Staley, had a close relationship with Jeffrey Epstein, was reportedly aware of Epstein’s criminal activities and may have even sexually assaulted a victim who had previously been trafficked by Epstein; (ii) if discovered, the relationship and potential criminal activity could bring reputational, legal, and financial harm to Company; (iii) the Company’s response to an inquiry by the British Financial Conduct Authority regarding Staley’s relationship with Epstein was materially false; (iv) when the Company became aware of information contradicting its response to the inquiry, it failed to update the response so that it would be accurate, or otherwise take any meaningful action; and (v) as a result, the Company’s statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action. Appointment as Lead Plaintiff is not required to partake in any recovery.
Shareholders have until January 2, 2024 to request that the court appoint them lead plaintiff.